Medicare Enrolled

Dr. George Liu, DPM

Foot & Ankle Surgery Podiatrist · Dallas, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Mixed engagement
INWOOD RD, Dallas, TX 75390
2146455713
In practice since 2006 (20 years)
NPI: 1841269958 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Liu from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Liu? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Liu

Dr. George Liu is a foot & ankle surgery podiatrist in Dallas, TX, with 20 years in practice. Based on federal Medicare data, Dr. Liu performed 773 Medicare services across 467 unique beneficiaries.

Between the years covered by Open Payments, Dr. Liu received a total of $23,783 from 27 pharmaceutical and/or device companies across 111 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in foot & ankle surgery podiatrist. The majority of payments are classified as financial or ownership interests (royalties, licensing fees, or investment interests). Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Liu is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ 773 Medicare services$ $23,783 industry payments

Medicare Practice Summary

Medicare Utilization ↗
773
Medicare services
Bottom 39% in TX for foot & ankle surgery podiatrist
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
467
Unique beneficiaries
$66
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~39 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (20-29 min)446$66$232
New patient office visit (30-44 min)95$82$347
Removal of skin of fingernail or toenail52$120$577
Cast supplies, short leg cast, adult (11 years +), fiberglass44$32$277
Betamethasone steroid injection40$4$28
Application of short leg cast25$63$346
Office visit, established patient (30-39 min)23$101$344
Aspiration and/or injection of fluid from medium joint21$38$212
Office visit, established patient (10-19 min)16$25$140
New patient office visit (45-59 min)11$123$533
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$23,783
Total received (2018-2024)
Avg $3,398/year across 7 years
Top 8% in TX for foot & ankle surgery podiatrist
27
Companies
111
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Financial / Ownership
Ownership or investment interests, royalties, and licensing fees
$10,086 (42.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,361 (22.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,138 (21.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$3,199 (13.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,565
2023
$5,037
2022
$3,681
2021
$7,049
2020
$42
2019
$1,367
2018
$2,041

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Gramercy Extremity Orthopedics LLC
$10,191
Orthofix Medical, Inc.
$4,292
Synthes GmbH
$3,841
Stryker Corporation
$1,408
Medical Device Business Services, Inc.
$1,115
Pylant Medical
$599
Horizon Pharma plc
$329
Kerecis Limited
$327
DePuy Synthes Sales Inc.
$278
Smith+Nephew, Inc.
$264
Integra LifeSciences Corporation
$174
Abbott Laboratories
$158
Cartiva, Inc.
$142
Melinta Therapeutics, Inc.
$121
Ortho Dermatologics, a division of Bausch Health US, LLC
$112
NuVasive Specialized Orthopedics, Inc.
$91
Ferring Pharmaceuticals Inc.
$75
Horizon Therapeutics plc
$54
Medtronic Vascular, Inc.
$52
OsteoCentric Technologies, Inc.
$45
Averitas Pharma Inc.
$27
Siemens Medical Solutions USA, Inc.
$19
Endo Pharmaceuticals Inc.
$17
TREACE MEDICAL CONCEPTS, INC.
$16
Nvision Biomedical Technologies, Inc.
$13
Tenex Health Inc.
$13
Pacira Pharmaceuticals Incorporated
$12
Top 3 companies account for 77.0% of total payments
Associated products mentioned in payments ›
ANCHORAGE · BME NITINOL CONTINUOUS COMPRESSION IMPLANTS · Baxdela · Cartiva · ClosureFast · DRG IPGs · DUEXIS · DUOBRII · Distal Fibula Plating System · EUFLEXXA · EVOS · EXPAREL · Foot/ankle products · HAMMERLOCK · HOFFMANN · INFINITY · Integra · JUNIORTHO PLATING SYSTEM · KRYSTEXXA · Kerecis Omega3 SurgiClose · Kerecis Omega3 Wound · LAPIPLASTY SYSTEM · MOTOBAND · Multitom Rax · NO_PRODUCT · ORTHOVISC · OsteoCentric 4.0 x 130mm LOCKING BONE SCREW FASTENER ST · PICO Single Use Negative Pressure Wound Therapy · PRECICE Intramedullary Limb Lengthening System · PRIMARY CARE - DISEASE STATE · QUTENZA · RAYOS · RINGFIX · Salto Talaris Total Ankle Prosthesis · TrueLok · VA-LCP PLATES & SCREWS · VARIAX · ViviGen · XCaliber Articulated Ankle Fixator · XIAFLEX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Payments are distributed across multiple categories with no single dominant type. Total industry engagement is in the top 8% for foot & ankle surgery podiatrist in TX.

Equivalent to $3,077 per 100 Medicare services performed
Looking for a foot & ankle surgery podiatrist in Dallas?
Compare foot & ankle surgery podiatrists in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse foot & ankle surgery podiatrists nearby

Geographic Context

Foot & Ankle Surgery Podiatrists within 10 mi
128
Per 100K population
4.9
County median income
$74,149
Nearest hospital
UT OF TEXAS SOUTHWESTERN UNIVERSITY HOSPITAL - WILLIAM P. CLEMENTS JR.
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Liu is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (mixed engagement, top 8%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Liu experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Liu performed 446 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Liu receive payments from pharmaceutical companies?
Yes. Dr. Liu received a total of $23,783 from 27 companies across 111 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Liu's costs compare to other foot & ankle surgery podiatrists in Dallas?
Dr. Liu's average Medicare payment per service is $66. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Liu) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →